Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Emery

Showing results (481-490 of 586) with videos related to

Pageof 59
Sort By:
Annals of the Rheumatic Diseases|September 6, 2008
Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot studyM H Buch, D L Boyle, S Rosengren, et al.
British Journal of Haematology|April 21, 2023
Considering equality in transfusion medicine practiceMark H Yazer, José R Díaz-Valdés, Darrell J Triulzi, et al.
Scientific Reports|October 3, 2018
Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical featuresY M El-Sherbiny, A Psarras, M Y Md Yusof, et al.
The Journal of Clinical Investigation|February 22, 2001
Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergyM Ali, F Ponchel, K E Wilson, et al.
Annals of the Rheumatic Diseases|October 22, 2005
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|April 1, 2008
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritisC Potter, K L Hyrich, A Tracey, et al.
Annals of the Rheumatic Diseases|November 6, 2004
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritisA D Fraser, A W R van Kuijk, R Westhovens, et al.
Scientific Reports|April 13, 2018
A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical featuresY M El-Sherbiny, A Psarras, M Y Md Yusof, et al.
Rheumatology (Oxford, England)|October 5, 2002
Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trialE H S Choy, G S Panayi, P Emery, et al.
Clinical Epigenetics|April 9, 2020
Differential CpG DNA methylation in peripheral naïve CD4<sup>+</sup> T-cells in early rheumatoid arthritis patientsR Pitaksalee, A N Burska, S Ajaib, et al.
Pageof 59

Showing results (481-490 of 586) with videos related to

Sort By:
Pageof 59
Annals of the Rheumatic Diseases|September 6, 2008
Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot studyM H Buch, D L Boyle, S Rosengren, et al.
British Journal of Haematology|April 21, 2023
Considering equality in transfusion medicine practiceMark H Yazer, José R Díaz-Valdés, Darrell J Triulzi, et al.
Scientific Reports|October 3, 2018
Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical featuresY M El-Sherbiny, A Psarras, M Y Md Yusof, et al.
The Journal of Clinical Investigation|February 22, 2001
Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergyM Ali, F Ponchel, K E Wilson, et al.
Annals of the Rheumatic Diseases|October 22, 2005
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|April 1, 2008
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritisC Potter, K L Hyrich, A Tracey, et al.
Annals of the Rheumatic Diseases|November 6, 2004
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritisA D Fraser, A W R van Kuijk, R Westhovens, et al.
Scientific Reports|April 13, 2018
A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical featuresY M El-Sherbiny, A Psarras, M Y Md Yusof, et al.
Rheumatology (Oxford, England)|October 5, 2002
Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trialE H S Choy, G S Panayi, P Emery, et al.
Clinical Epigenetics|April 9, 2020
Differential CpG DNA methylation in peripheral naïve CD4<sup>+</sup> T-cells in early rheumatoid arthritis patientsR Pitaksalee, A N Burska, S Ajaib, et al.
Pageof 59